Published on Tuesday November 11, 2014
Smooth has conducted an Investigator’s Meeting in Moscow
Smooth Drug Development has conducted an Investigator’s Meeting.
Smooth Drug Development has conducted an Investigator’s Meeting in Moscow on November 6-7.
The meeting was dedicated to discussing important aspects of clinical trials conduct of a new antioxidant drug for stroke treatment.
Principal Investigators and sub-investigators from 15 leading sites from St-Petersburg, Moscow, Novosibirsk, Samara, Yaroslavl and Kazan discussed operational questions connected with the phase III clinical trial conduct. The study is sponsored by a leading pharmaceutical company in Russia.
The following topics were covered at the meeting:
- Study design and Protocol procedures
- Source documents
- CRF completion
- Use of scales
- Study team responsibility
- ICH GCP